ʻeho peni mäka HI-125

CA 125 Ua noʻonoʻo pono kiʻekiʻe hakakino kaumaha glycoprotein, o ka antigen. Ua lŘlŘ ka derviatov mai coelomic epithelium fetal'aʻaʻa a me ka mea i loaʻa i loko o maʻamau endometrial'aʻaʻa, mucinous a me ka serous makuwahine lama. I ke koko, aole ia i komo iloko, koe nae ma na hihia o ka luku ana o maoli o ke'ākeʻakeʻa mai.

I ka lehulehu ma ka lāʻau lapaʻau hiki e papalua i loko o ka menstrual manawa, ma ka pakahi endometriosis. ʻeho peni mäka CA 125 hiki ke kiʻekiʻe ma ka trimester mua o ka hāpai keiki. A hōʻemi iki mahuahua i ola wahine aie i kona hoʻololi kemikala i loko o ka pleural, peritoneal lua, bronchial epithelium, ka pericardium, ka fallopian paipu; kane - hoʻololi kemikala i loko o ka epithelium o na testes.

I Kekahi Mauʻeho peni mäka CA-125 ke huai aeʻeho metastasis i loko o na mahina eono i mua o ka hoouka kaua ana o lapaʻau hoike ana (hoike ana). Keia mea i mea e hiki ai e loiloi i ka pākōlea hopena i loko o ka iapaau ana o ka maʻi.

ʻeho peni mäka CA-125 mea o ka nui i loko o kaʻike, o ovarian Ka maʻi 'aʻai. Ka mea o loko ua muli ma ka ka loaʻaʻana o ke kiekie nā hoʻohui like o antigens i loko o ke koko. Kēia mau ho'ākāka 'ona hoike o kaʻeho? Acaeoey. Oia antigens nā kekahi hormones, nā'ūhū, neoneo huahana a me nā neoplasms.

Ka Ikepili o kaʻeho hōʻailona ho'ākāka 'ia no ka CA 125

Kūmau - 35 huahelu / ml. Ke mahuahua ma kaʻilikai ma ke kala ana (i mea hoʻonāwaliwali maoli) ua noʻonoʻo pono i ke kumu no ka oi hoʻomanawanui anamanaʻo e kuhikuhi i ka recurrence o ka maʻi. Ana mahuahua Hawaiʻi Hōʻike e holumua ai papa o kaʻeho kaʻina, a hua mai la i ka adverse naoh i ka lapaau.

Ka Ikepili o kaʻeho peni mäka CA 125 mai ka haʻahaʻa specificity. I kulike ai me ka ana heluʻikepili elua-pa mahuahua ana o kona pae i loko o ke koko lāʻau lapaʻau, ka oi aku i loko o nā mea maʻi mua o kanalima-kumamalima makahiki, i ka ike loea PAaIEN o ka hooulu ana mai o ovarian Ka maʻi 'aʻai.

Ma waena o ka lawe ana o kekahi laʻana, a pono e ma ka liʻiliʻi loa ewalu (kaʻoi loa, o ka papa, e ma ka liʻiliʻi loa umikumamalua) hola ka hope hokii, o ka meaʻai. Oe ke ole inu kī, wai a me ke kope. Aeia mai e hoʻohana i ka wai.

Mahuahua ana o ka antigen ma ka lāʻau lapaʻau Hōʻike Ka maʻi 'aʻai:

- ma ka pancreas, mammary gland;

- ovaries, endometrium, uterus, fallopian paipu ;

- akepaa, opu, rectum;

- malamalama;

- 'ē aʻe malignancies.

A nui mahuahua ma ka hana ike me ka hikoko ma ka digestive'āpana, a me ka umauma bronchi. Nolaila, i ka pololei diagnose Ka maʻi 'aʻai ka nānā' ana ma luna o Ka Ikepili o wale ka CA 125 mea,ʻaʻole hiki. No ka mea, o keia, mea, mea pono e hoʻomaka aiiieieoaeuiuo iiauo haʻawina.

A hōʻemi iki ulu i loko o ka CA 125 ke hana i loko o benign gynecological malignancy ano, a me keʻano o ka hanaʻana hoʻoʻino pili i appendages. No ka maʻi a me nā kumu pili me ka uuku mahuahua i loko o ka nui o ka antigen nā:

- ovarian cyst;

- endometriosis;

- li nui o na appendages;

- pleurisy, peritonitis;

- STD;

- menstruation;

- cirrhosis, maʻi hepatitis;

- maʻi pancreatitis;

- kekahi autoimmune maʻi.

Me ka hooulu ana o benign hikoko a me ka hoʻoʻino keʻano o ka hanaʻana,ʻeho peni mäka CA 125 i oi aku mamua o 100 U / ml. Loina nui pela ma ke kālailaiʻana i ka pākōlea hopenaʻoi loa o nā'āpana hana e hoʻohana ', a me ka preclinical ka loaʻaʻana o ka recurrence o endometriosis.

CA 125 Ua noʻonoʻo oncomarker serous carcinoma i loko o ka ovary. Kona Index o 150-200 huahelu / ml Hōʻike komo i loko o ka pathology o serous membranes. Ma keia mea nui ka mālamaʻana kona lehulehu i loko o ka loiloi 'ana i ka laulā o keʻoki kino a me ka chemotherapy. Ma ka hihia o ke anakahi i loko o ke koko hysterectomy hoemi ia i ka umi iniha, no mililika me. Hoomahuahua ae la lakou i ka 35 U / ml Hōʻike he kaʻina relapse.